RE:Slow WalkHi Justforfun,
There shouldn't be any reason to "slow walk" the phase 2b/3 trail because of the IV formulation, this study is using 20 mg TID of NP-120 in oral pill form, not IV. As per the start date, it is stated on clinicaltrials.gov that the anticipated start date for the trial is July 2020. Also, as per the Vancouver Sun article from yesturday, Chris Moreau stated that they anticipate the start date to be "within the next 2 months", we are in early June so this is in line with the clinicaltrial.gov date of July. As for South Korea, as I have explained in the past, they have been excellent at mitigating the virus and Busan has only had 1 positive in the past few weeks. they can't run a trial if they can't get the patients.
Justforfun10 wrote: I could be wrong but it seems the trials are being slow walked until the IV formulation is achieved and toxicology tests are done. So the IV delivery may not be available until August or September. Could be they are trying to protect their proprietary interests. Disappointing that the Korean trial has yet to start. I see no compelling reason to buy this stock and it will probably drift down to 25 cents until the Cdn and US trials begin. Realistically I dont see them occuring until August at the earliest.